Close Menu
NEW YORK (GenomeWeb News) — Transgenomic yesterday said third-quarter revenues rose 6 percent as R&D spending increased 23 percent and net loss widened by nearly 25 percent.
 
Total receipts for the three months ended Sept. 30 rose to $5.2 million from $4.9 million year over year.
 
Transgenomic CEO Craig Tuttle said in a statement that the increase in revenue “reflects continued growth in our molecular diagnostics reference lab and Pharmaceutical Services businesses.”
 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Oil made from gene-edited soybeans is already in use, according to the Associated Press.

USA Today reports that Department of Veterans Affairs is teaming up with Sanford Health to provide veterans with genetic testing.

Mother Jones reports there are few regulations overseeing the use of genetic genealogy by law enforcement.

In Science this week: analysis of ancient DNA recovered from Iberian populations, and more.